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2Sammanfattning
Severe Combined Immunodeficiency (SCID) är en immunbristsjukdom med genetisk
bakgrund som förekommer hos Arabiska fullblod och korsningar med dessa. Sjukdomen har
varit känd och dokumenterad sedan 1970-talet och tidigt föreslagen som en autosomal
recessiv sjukdom.
Föl som är drabbade av sjukdomen producerar varken B eller T lymfocyter och dör efter en
kort tid i följdsjukdomar som uppstått p.g.a. bristande immunförsvar. Den vanligaste
dödsorsaken är lunginflammation orsakat av adenovirus. Det är svårt att hålla föl som är
drabbade av SCID vid liv. Man har dock lyckats förlänga deras liv genom att ge injektioner av
plasma innehållande antikroppar. Även en benmärgstransplantation har utförts där fölet
överlevde.
Under 1990-talet utvecklades ett gentest för kontroll av bärare av sjukdomen vilket har gjort
det möjligt att bestämma om en häst är bärare av genen utan att använda sig av testparningar.
De uppskattningar av frekvensen heterozygoter som utfördes innan testet utvecklades var
baserade på kliniska undersökningar av de föl som misstänktes vara drabbade av sjukdomen.
Dessa uppskattningar visade sig senare ha överskattat frekvensen anlagsbärare.
I Sverige är frekvensen bärare av SCID låg och avel på dessa är förbjuden. Förbudet följs
dock inte upp i praktiken då hästar endast testas för SCID då de misstänks vara bärare. Om
heterozygoter bör få ingå i avel borde avgöras av populationens storlek och av frekvensen
anlagsbärare. Den totala populationen Arabiska fullblod i Sverige är så stor att bärare bör
uteslutas från avel.
Abstract
Severe Combined Immunodeficiency (SCID) is a disease with a genetic background in
Arabian horses and crossbreeds with Arabians. The disease has been known and documented
since the 1970’s and was early suggested to have an autosomal recessive mode of inheritance.
Foals that are affected with SCID lack production of both B and T lymphocytes and
consequently die from secondary diseases within a short period of time. The most common
cause of death is infections in the respiratory tract caused by adenovirus. Maintaining foals
affected with SCID has been proven difficult, but their lives can be prolonged with injections
of hyperimmune plasma. A successful bone marrow transplant has also been performed.
A DNA-test for detection of carriers of the defective allele was developed during the 1990’s.
The test made it possible to detect whether a horse was a carrier or a non-carrier of SCID,
without the use of test mating. Previous estimations of the frequency of the defective allele
were based on clinical diagnosis on foals suspected to be affected with SCID. These studies
were later found to have overestimated the frequency of carriers.
The frequency of SCID carriers in Sweden is low and carriers are not allowed in breeding.
The present legislation is however not acted upon since horses are only tested for SCID if
suspected to be carriers. The question whether heterozygotes should be allowed in breeding or
not should be decided while considering the population size and the frequency of carriers. The
total population of Arabian horses in Sweden is large enough to exclude carriers from
breeding.
3Introduction
Severe Combined Immunodeficiency (SCID) is a genetic disease that has been observed in
humans, dogs, mice and horses (McGuire & Poppie, 1973; McGuire et al., 1975; Bosma et al.,
1983; Felsburg et al., 1999). Horse breeds affected with SCID are Arabian horses and Arabian
crossbreeds (Swinburne et al., 1999). Foals that are born with the genetic defect are unable to
produce functioning B and T lymphocytes and consequently die within a few months from
infections due to their insufficient immune defence. SCID is a recessive disease which means
that in order to express it, the individual has to inherit the gene from both parents. Therefore,
mating carriers with non-carriers will never produce an affected foal.
A reliable DNA-test to determine whether an individual is a carrier of the defective gene or
not was developed in 1997 (Shin et al., 1997a). This test makes it possible to exclude carriers
from breeding without using test mating to determine if they are carriers or not.
The frequency of the defective gene differs from population to population, and different
countries might not even have the same view on breeding with carriers of recessive alleles.
This literature study aims to summarise what is known about the disease at present time, the
gene frequency in Sweden and in the rest of the world, and to conclude whether carriers
should be accepted in breeding or not.
Background
SCID was first termed combined immunodeficiency (CID), the term severe was added later to
standardise the nomenclature (Studdert, 1978). SCID was first described in 1973 by McGuire
and Poppie who studied two Arabian foals and tissues from other deceased foals. Both foals
had pneumonia and did not respond to antibiotic therapy. Blood samples showed remarkably
low concentration of lymphocytes. When lymphoid tissues of the foals were studied, lack of
lymphocytes was found as well. The authors came to the conclusion that the foals had a
defective B-lymphocyte system leading to a lack of immunoglobulin synthesis. Evidence that
the disease was of genetic origin was found, such as the presence of SCID in full siblings and
several reported cases in Arabian foals whereas no reported cases in any other breeds were
found.
Foals affected with SCID lack functioning B and T lymphocytes (McGuire and Poppie, 1973).
Lymphocytes are white blood cells that carry out the adaptive immune responses and are
found in large numbers in the blood, lymph and lymphoid organs such as the spleen and
thymus (Alberts et al, 2002). B and T lymphocytes constitute the two main classes. B
lymphocytes produce antibodies, which are proteins called immunoglobulins. T lymphocytes
kill cells that are infected with viruses and regulate the activities of other white blood cells.
SCID has probably been around for a long period of time, only never considered to be a
hereditary disease. Poppie and McGuire confirmed the mode of inheritance through test
mating in 1977. They showed that a simple recessive mutation was the cause of the disease.
Studies of pedigrees have indicated that a stallion that was active in breeding in the early parts
of the twentieth century in the USA, might be the source of the mutation (Bernoco and Bailey,
1998; Swinburne et al., 1999).
4Pathological picture
Symptom and clinical diagnosis
Foals affected with SCID are susceptible to microbial infections due to their lack of a
functioning immune system and usually die before 5 months of age (Poppie and McGuire,
1977; Perryman and McGuire, 1978; Swinburne et al., 1999). Symptoms are fever,
pneumonia, coughs, nasal discharges, diarrhoea and infections (McGuire and Poppie, 1973;
Swinburne et al., 1999). In the first 1-3 months of life, foals are protected by
immunoglobulins received from their dams via colostrum, but these are eventually eliminated
by the catabolism, causing a lack of resistance against infections (Perryman, 2000). There are
some conditions that could be mistaken for SCID, such as failure in the passive transfer of
immunoglobulins (FPT) from dam to foal via colostrum (Poppie and McGuire, 1976). Foals
with FPT have immunoglobulin M (IgM) in their serum from birth whereas foals affected
with SCID have no IgM within 2 to 3 weeks after birth.
Perryman and McGuire (1978) found in a study of 66 foals affected with SCID that infections
in the respiratory tract were the predominant disorder. The infections were mainly caused by
adenovirus which was the main cause of death, but several kinds of bacteria and the protozoan
Pneumocystis carinii caused infections as well. Significant bacterial lesions were found in
lever, pancreas, intestines, heart and kidneys.
Before the development of a DNA-test for SCID, foals were diagnosed clinically. Perryman
and Torbeck (1980) established the criteria for determining if a foal had in fact died from
SCID or not. The criteria foals had to meet to be diagnosed with SCID were (1) to have
lymphopenia, (2) a lack of immunoglobulin M, (3) to have lymphocytes that respond little or
not at all to stimulation of the antigen phytolectin in vitro and (4) to have hypoplastic
alterations of spleen, thymus and lymph nodes.
Treatment
The main obstacle in maintaining foals with SCID alive for experimental reasons is to be able
to control the respiratory tract infections (Perryman and McGuire, 1978). Perryman and
McGuire (1978) placed affected foals in semi-isolation with their dams in their study of 66
foals affected with SCID. The foals were given hyperimmune plasma intravenously twice a
week and antibiotics when bacterial infections developed. The four foals that were treated
with plasma injections were maintained for 3-11 months without any signs of adenovirus-
infection. The plasma also contained antibodies against other microbial agents. Seven foals
that were given insufficient amounts of plasma or none at all died between 2 and 4 months of
age due to severe adenovirus infections.
Bue et al. (1986) reported of a 32-day-old horse with SCID that had a successful bone marrow
transplant from a sex-matched full sibling donor. The recipient foal reached normal B and T
lymphocyte values 170 days after the transplant and when immunised with bacteriophage, the
foal showed an antibody response which had not been observed in untreated SCID foals. The
foal survived to five years of age when it died from causes unrelated to SCID and the
transplant (Perryman, 2000).
5Genetic background
Mode of inheritance
Poppie and McGuire suggested as early as 1973 that SCID was inherited as an autosomal
recessive trait (Figure 1). This was supported with the fact that the dam and sire of the foals in
the study had no history of immunodeficiency and that both a female and a male foal that
were affected were found.
Figure 1. Inheritance of an autosomal recessive trait. The diagram shows the outcome of mating
between two horses that are heterozygous for the SCID trait. 50% of the offspring will be
heterozygotes i.e. carriers, 25% will be homozygous for the dominant allele and 25% will be
homozygous recessive i.e. affected with SCID.
Poppie and McGuire (1977) later determined the mode of inheritance through test mating of
17 mares to 1 of 10 stallions for a total of 22 matings. All mares and stallions had previously
produced offspring affected with SCID. The matings resulted in 22 foals out of which 7 had
SCID, which is slightly higher than the expected outcome of 25% (5.5/22) but still supports
an autosomal recessive mode of inheritance. The difference in expected to actual outcome of
affected foals could be explained by the small numbers of horses studied.
The mode of inheritance was confirmed in a larger study performed by Perryman and Torbeck
(1980) who test mated 26 mares that had previously produced offspring affected with SCID to
a stallion that also had offspring affected with SCID. The study was performed over a time
period of three years and gave a total of 50 living foals, two aborted foetuses and one stillborn
foal. The stillborn foal and the two aborted foetuses were determined to be nonaffected as
they had IgM and well-developed lymphoid tissues. Of the 50 other foals, 15 were affected
with SCID which gave a percentage of 28.3% (15/53) affected. With a larger group of tested
individuals it is reasonable to assume that this number would come closer to 25%. The
distribution was 25:28 between male and female foals and between foals affected with SCID
7:8. The even distribution between males and females supports an autosomal mode of
inheritance and also supports previous results by Poppie and McGuire (1977), where 4 males
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6and 3 females where affected. Precise criteria, described by Perryman and Torbeck (1980),
were used to classify the foals as affected or nonaffected. They could exclude that the disease
would be inherited by a sex-linked recessive pattern as there would then have been more
affected males than females. A dominant pattern of inheritance could also be excluded since
both sire and dam were unaffected.
Molecular mechanism
The genetic defect responsible for SCID is a five base pair deletion (Figure 2) in the gene
encoding for the catalytic subunit (DNA-PKcs) of DNA-protein kinase (DNA-PK) (Shin et
al., 1997a). The base pair deletion causes a frame-shift mutation at codon 3155 of the
transcript, resulting in deletion of the 967 following amino acids which causes a non-
functional enzyme. The DNA-PK enzyme is usually involved in the mechanisms of V(D)J
recombination during early lymphoid differentiation where it is required for the repair of
DNA double-strand breaks (Wiler et al., 1995; Shin et al., 1997a; Alberts et al., 2002). The
V(D)J recombination reaction generates diverse T-cell receptors and immunoglobulin
molecules that are necessary for recognition of foreign antigens. Because the lack of DNA-PK
leads to an inactivation of V(D)J recombination, SCID affected foals have a block in the B
and T lymphocyte development (Shin et al., 1997a; Shin et al., 1997b).
Normal Gene .....AATTTATCATCTCAAATTCCCCTTAA.....
SCID Gene .....AATTTATCA     AATTCCCCTTAA.....
Figure 2. Partial sequence of the DNA-PKcs gene showing the 5 base pair deletion in the mutated
SCID gene (Shin et al., 1997a). The mutation results in a frame-shift which causes a premature stop.
Bailey et al. (1997) demonstrated with fluorescence in situ hybridisation (FISH) that the
mutated gene responsible for SCID is located on equine chromosome ECA9p12. Shin et al.
(1997b) found in their study of 17 carriers, 4 affected foals and 1 healthy foal (whose dam and
sire where carriers), that all horses had the same DNA-PKcs mutation, which supports
previous results by Shin et al. (1997a). Since all tested horses had the same mutation it is
likely that the DNA-PKcs allele has a common origin that results from a genetic “founder”
effect.
DNA-test for identification of carriers
The discovery of a five base pair deletion responsible for SCID led to the development of a
Polymerase Chain Reaction (PCR) based test for detection of SCID carriers (Shin et al.,
1997a). The normal and SCID equine DNA-PKcs transcripts were cloned and sequenced with
PCR based technology. Two oligonucleotide hybridisation probes, scanning the region of
deletion, where synthesised representing the normal (N probe) and SCID (S probe) sequences.
The S probe, specific for the mutated allele, hybridises in the foals affected with SCID
whereas the N probe, specific for the normal allele, does not. In horses that do not carry
SCID, only the N probe hybridises. In animals that are heterozygotes, both the N and S probes
hybridise.
The test is an important asset in the development of breeding programs and makes it possible
to avoid ever letting a SCID foal be born (Perryman, 2000). It also makes it possible to
determine if a foal should be treated or not since there is little point in treating a foal affected
with SCID except for study purposes. With the test it is possible to determine that a horse is
free of the defective allele whereas with progeny testing, one can never be 100% sure that the
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carried out by ‘Husdjursgenetiska laboratioret’ SLU, Uppsala. The cost of the test was in
April 2007, 650 SEK  per horse (SLU’s homepage, 2007).
The whole horse genome was sequenced by February 2007 which presents a wide range of
new opportunities to study the origin of genetic defects in horses (National Institutes of
Health, 2007). All nucleotides in the equine DNA-PKcs allele were however already
sequenced, but the entire sequencing of the horse genome could provide material for future
studies.
Frequency
Before the development of a genetic test for carriers of the defective allele, estimations of the
gene frequency was based on clinical identification of foals affected with SCID (Swinburne et
al., 1999). This method of estimation is not as accurate as a gene test and gave an
overestimation of the prevalence of the defect. The overestimation could be explained by a
non random selection of horses. It is likely that populations where SCID was suspected to be
present were selected and that breeders who had experienced a problem with the defect were
interested in having their horses being a part of the research. Another explanation is that foals
were wrongly suspected to have died due to SCID when they in fact did not (Bernoco &
Bailey, 1998; Swinburne et al., 1999). Poppie and McGuire (1977) expressed that the high
frequency of SCID suggested that the defect had been selected for unknowingly, when
selecting for another desirable trait. The frequency of carriers i.e. heterozygotes were
calculated using the law of Hardy-Weinberg equilibrium; A/A: p2, A/a: 2pq, a/a: q2, where p is
the frequency of allele A, q is the frequency of allele a and p + q =1 (Griffiths et al., 2005).
A/a are heterozygous horses, while foals affected with SCID are homozygous for the
defective allele and hence a/a. Hardy-Weinberg equilibrium is the stable frequency
distribution of the different genotypes and is achieved when mating is random and no
mutation, migration, natural selection or random drift occurs.
Poppie and McGuire (1977) estimated the frequency of carriers in the USA to be 25.7% in
1977, based on 2-3% affected foals. The method used to determine if a foal was affected was
clinical identification, which was performed on 257 foals from 19 different states. In the late
1990’s, Bernoco and Bailey (1998) estimated the frequency of carriers in the USA by using
the new DNA test (Shin et al. 1997a) on 250 randomly selected Arabian horses. The
frequency of carriers was estimated to be 8.4% which was far less than Poppie and McGuire’s
(1977) result. The likely occurrence of affected foals would then be 0.18%, which is 11 to 16
-fold less compared to Poppie and McGuire’s result.
Another study to determine the number of carriers by DNA-testing was carried out in the UK
in 1999 by Swinburne et al. They randomly selected and tested 106 blood samples which
were taken previously during 1997 and 1998. They found that 2.8% of the tested horses where
carriers. The frequency of carriers could be estimated to be between 1-5% in the UK at 95%
confidence level using that sample size.
Poland has a total population at about 1500 Arabian horses and has been an important
exporter of Arabian horses to several countries (Terry et al., 1999). In a test performed in
1999, 271 Polish Arabian horses were selected and tested for the mutated allele. These horses
were selected to represent the major blood lines of Arabian horses in Poland. None of the 271
8horses were carriers of the mutated allele which indicates that the allele is rare if present in the
Polish population.
The Swedish population
Arabian horses in Sweden are only tested for SCID when evaluated for breeding if suspected
to be heterozygous (the Swedish Horse Board’s homepage, 2007). Stallions and mares that are
found to be carriers are not allowed in breeding.
In a small study performed in Sweden during 2000 – 2001, 122 Arabian horses were tested for
the SCID gene (Sandberg K., personal communication). The horses selected for the study
were not closely related. Only two horses were found to be carriers which give a carrier
frequency of 1.64%. This material is however not sufficient to draw definite conclusions
from.
The effective population size (Ne) can be calculated using the equation: Ne≈ (4Nm x Nf)/(Nm +
Nf), where Nm and Nf are the number of males and females used in breeding (Falconer, 1996).
This is however not true if there is variation in family size, and a more correct definition of Ne
is calculated as Ne=1/2∆F, where ∆F is the rate of inbreeding. As the rate of inbreeding in the
Swedish Arabian horse population was not known, a rough estimation of Ne was calculated
with use of the former equation. Using available data from 2005 when 70 stallions and 278
mares were used in breeding, the effective population size was estimated to 224 individuals
(Swedish Horse Board, 2005). The total Arabian horse population in Sweden has been
estimated to approximately 7,000 horses (World Arabian Horse Organisation’s homepage,
2007).
Compared with horses of other breeds in Sweden, the Swedish Arabian horse population is
average in size (Swedish Horse Board, 2005). The effective population size seem to be about
the same size as for Swedish Ardennes horses and New Forest ponies (Ne =237 and 192,
respectively). The Swedish Arabian horse population is small in comparison to the Swedish
Warmblood who has an effective population of 833 individuals.
Laws and recommendations
As for breeding, Perryman (2000) points out that two heterozygotes never should be mated to
each other. If it is of interest to preserve a certain blood line through a horse found to be
heterozygous, it should only be mated to a horse that is determined to be homozygous normal.
The offspring from such mating should be tested and only if found to be homozygous normal,
be allowed to be used in breeding. Jones (1997) expressed that not only should stallions be
tested for SCID, but mares should be tested as well before being used for breeding.
In the Swedish government’s agricultural act 1999:106 on animal welfare demands regarding
breeding, issues that have to be considered are regulated (Swedish department of agriculture’s
homepage, 2007a). According to 3 §, breeding with horses that inherit lethal genes to its
offspring is prohibited. Breeding with carriers of lethal alleles is not acceptable from an
animal welfare perspective (Swedish Animal Welfare Agency’s homepage). Breeding with
carriers lead to an increased prevalence of the defective gene.
Since December 1st 2005, it is voluntary to evaluate stallions for breeding (Swedish
department of agriculture’s homepage, 2007b). It is now up to the breeding organisation for
each breed to decide whether this is a demand or not. Breeders are not obligated to evaluate
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This means that carriers could be used in breeding in Sweden even though the law prohibits it.
The Swedish Arabian Horse Association (SAHF) recommends stallions to be evaluated for
breeding. They can however not deny registration of Arabian horses that are not evaluated as
they are obligated to register horses that are registered in the World Arabian Horse
Organisation (SAHF’s homepage, 2007).
Discussion
It is not likely that the frequency of the SCID gene in the USA has been reduced so drastically
since first estimated just by selection (Bernoco and Bailey, 1998). The frequency was most
likely overestimated due to non-random selection.
Even though Bue et al. successfully cured a SCID affected foal through bone marrow
transplant, it has little value in practice (Perryman, 2000). Such a foal still has the same
genetic makeup and would transfer the defective gene to its offspring and should for that
reason never be mated.
A larger study with DNA-testing would give a reliable determination of the frequency of
SCID carriers in the Swedish Arabian horse population. Those few horses that are carriers and
are used in breeding in Sweden, could easily be replaced by non carriers from the total
population. Arabian horses that are free from the mutated allele could also be imported from
other parts of the world. In this way the effective population size will remain the same, not
increasing inbreeding, when excluding carriers from breeding. The breeding progress could
however to some extent be slowed down if some of the best horses are excluded on the basis
that they are carriers. If testing all horses active in breeding and only allowing SCID free
horses, the need for testing will only be temporary as no new carriers will be produced.
Horses that are imported will need to be tested before being part of breeding. The cost of the
DNA test is just a fraction of the cost in money and time that it takes to produce a foal.
Complete elimination of the SCID gene from the world population would be the ultimate aim
for the future. If carriers are allowed in breeding in other countries, they should only be mated
with non carriers. The method in which to eliminate carriers in these countries should be
immediate or possibly gradual withdrawal of carriers from breeding. Carrier to carrier mating
should not be allowed due to the high risk of the outcome of an affected foal. With reliable
DNA testing, it is possible to assure this will never happen.
Conclusions
The aim should be to eliminate the carriers of SCID in Sweden through breeding by following
present legislation. In other countries where mating with carriers of lethal genes is allowed,
carriers should only be mated to non-carriers and this type of mating should be reduced and
ultimately terminated.
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